A 6-year-old child with sickle cell disease develops sudden onset of severe headache, focal neurological deficit, and altered consciousness. What is the most common type of stroke in pediatric sickle cell disease?
A. Venous sinus thrombosis
B. Subarachnoid hemorrhage from arteriovenous malformation
C. Ischemic stroke from large artery occlusion (moyamoya-like syndrome)
D. Hemorrhagic stroke from ruptured aneurysm
Explanation
Most Common Type of Stroke in Pediatric SCD
Key Point
Ischemic stroke from large artery occlusion (particularly affecting the middle cerebral artery and internal carotid artery) is the most common type of stroke in children with sickle cell disease, often associated with a moyamoya-like pattern of collateral vessel development.
Stroke in SCD: Epidemiology and Pathophysiology
Incidence:
Occurs in ~11% of children with SCD by age 20 years (untreated)
Second leading cause of death in SCD (after acute chest syndrome in adults)
Chronic stenosis → moyamoya-like collateral development
5.
Hemodynamic compromise during pain crisis or infection
Stroke Types in SCD: Frequency Comparison
Table
Type
Frequency
Mechanism
Clinical Feature
Ischemic (large artery)
70–80%
Vaso-occlusion, thrombosis
Acute focal deficit, MCA/ICA territory
Hemorrhagic
10–20%
Rupture of collateral vessels, hypertension
Sudden severe headache, ICH
Venous thrombosis
Rare
Hypercoagulability, dehydration
Seizures, focal deficit
Subarachnoid
Rare
Ruptured aneurysm or collateral
Sentinel headache, meningismus
High-YieldNEET PG
Transcranial Doppler (TCD) ultrasound is the gold standard for stroke risk stratification in children with SCD. Elevated blood flow velocity (>200 cm/s) predicts high stroke risk and is an indication for chronic transfusion therapy.
Clinical Pearl
The moyamoya-like syndrome in SCD develops due to chronic stenosis of large intracranial vessels with compensatory proliferation of fine collateral vessels, creating a characteristic "puff of smoke" appearance on angiography. This is distinct from primary moyamoya disease but functionally similar.
Mnemonic — Stroke Prevention in SCD: "TRANSFUSE"
Transcranial Doppler screening (TCD)
Risk stratification (elevated velocity)
Acute management (thrombolytics contraindicated in SCD)
Neuroimaging (MRI/MRA)
Stroke prevention (chronic transfusion)
Follow-up imaging
Use of hydroxyurea (reduces stroke risk)
Support and rehabilitation
Education on warning signs
Warning
Thrombolytic therapy (tPA) is generally contraindicated in acute ischemic stroke in SCD due to risk of hemorrhagic transformation and sickling complications. Management focuses on exchange transfusion to lower HbS levels and supportive care.
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.